Janux Therapeutics (JANX) Amortizatization of Intangibles (2021 - 2026)

Janux Therapeutics (JANX) has reported Amortizatization of Intangibles for 6 consecutive years, with $2.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Amortizatization of Intangibles fell 37.83% year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at $16.0 million (up 22.72% YoY), while the FY2025 annual figure was $17.6 million, up 66.03% from the prior year.
• Amortizatization of Intangibles declined to $2.6 million in Q1 2026 per JANX's latest filing, from $3.5 million in the prior quarter.
• Across five years, Amortizatization of Intangibles topped out at $5.2 million in Q2 2025 and bottomed at $24000.0 in Q1 2022.
• Historically, Amortizatization of Intangibles has averaged $2.4 million across 5 years, with a median of $2.1 million in 2023.
• Annual changes were most pronounced in 2023 — Amortizatization of Intangibles surged 6891.67% — and 2026, when it tumbled 37.83%.
• Janux Therapeutics' Amortizatization of Intangibles stood at $1.3 million in 2022, then jumped by 59.52% to $2.1 million in 2023, then surged by 42.02% to $2.9 million in 2024, then climbed by 20.4% to $3.5 million in 2025, then fell by 25.54% to $2.6 million in 2026.
• Business Quant data shows JANX's Amortizatization of Intangibles at $2.6 million in Q1 2026, $3.5 million in Q4 2025, and $4.6 million in Q3 2025.